UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.433

Sortiert nach

Worry and regret in the prospective multicentre TUBA study in mutation carriers

Gynecologic oncology, 2019-06, Vol.154, p.22

2019

Link zum Volltext

Verfügbarkeit prüfen

Randomized trial of adjuvant chemotherapy versus concurrent chemoradiotherapy in early-stage cervical cancer after radical surgery: A Chinese Gynecologic Oncology Group study (CSEM-002)

Gynecologic oncology, 2018-06, Vol.149, p.30-30

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification of ovarian cancer patients for immunotherapy by concurrent assessment of tumor mutation burden (TMB), microsatellite instability (MSI) status, and targetable genomic alterations (GA)

Gynecologic oncology, 2018-06, Vol.149, p.36-36

2018

Link zum Volltext

Verfügbarkeit prüfen

Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance

Gynecologic oncology, 2015-02, Vol.136 (2), p.178-182

2015

Link zum Volltext

Verfügbarkeit prüfen

Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer

Gynecologic oncology, 2018-10, Vol.151 (1), p.10-17

2018

Link zum Volltext

Verfügbarkeit prüfen

Highlights from the Society of Gynecologic Oncology 2017 Annual Meeting on Women's Cancer

Gynecologic oncology, 2017-06, Vol.145 (3), p.483-485

2017

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix” [Gynecol. Oncol. 145 (2017) 284–290]

Gynecologic oncology, 2017-08, Vol.146 (2), p.440-440

2017

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to ‘Tumor diameter as a predictor of lymphatic dissemination in endometrioid endometrial cancer’ [Gynecol. Oncol. 141 (2016) 199–205]

Gynecologic oncology, 2017-03, Vol.144 (3), p.649-649

2017

Link zum Volltext

Verfügbarkeit prüfen

Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A Trans PORTEC initiative

Gynecologic oncology, 2017-08, Vol.146 (2), p.327-333

2017

Link zum Volltext

Verfügbarkeit prüfen

A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer

Gynecologic oncology, 2019-10, Vol.155 (1), p.63-68

2019

Link zum Volltext

Verfügbarkeit prüfen

A comparison of tumor size at diagnosis and disease recurrence in type I and type II endometrial carcinoma

Gynecologic oncology, 2017-06, Vol.145, p.132-132

2017

Link zum Volltext

Verfügbarkeit prüfen

Role of lymphadenectomy and adjuvant treatment in high-risk endometrial cancer with positive lymph nodes: Comparison of a historical series with comprehensive surgical staging and a contemporary series with sentinel lymph nodes

Gynecologic oncology, 2017-06, Vol.145, p.58-58

2017

Link zum Volltext

Verfügbarkeit prüfen

Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy

Gynecologic oncology, 2017-06, Vol.145, p.20-20

2017

Link zum Volltext

Verfügbarkeit prüfen

Mortality reduction and cost-effectiveness of performing hysterectomy at the time of RRSO for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers

Gynecologic oncology, 2017-06, Vol.145, p.45-45

2017

Link zum Volltext

Verfügbarkeit prüfen

Sentinel lymph node biopsy for early cervical cancer: Five years follow-up of a diagnostic, prospective, multicenter study (Senticol 1)

Gynecologic oncology, 2017-06, Vol.145, p.92-93

2017

Link zum Volltext

Verfügbarkeit prüfen

No need to stress: Prospective clinical trial of adrenergic blockade during primary treatment in women with epithelial ovarian cancer

Gynecologic oncology, 2017-06, Vol.145, p.33-34

2017

Link zum Volltext

Verfügbarkeit prüfen

Sentinel lymph node biopsy for early cervical cancer: Results of a randomized prospective, multicenter study (Senticol 2) comparing adding pelvic lymph node dissection vs sentinel node biopsy only

Gynecologic oncology, 2017-06, Vol.145, p.2-3

2017

Link zum Volltext

Verfügbarkeit prüfen

Recurrence patterns after minimally invasive surgery for cervical cancer: Outcomes compared to traditional surgery

Gynecologic oncology, 2017-06, Vol.145, p.159-159

2017

Link zum Volltext

Verfügbarkeit prüfen

Hospital readmission as a quality measure in ovarian cancer surgery

Gynecologic oncology, 2017-06, Vol.145, p.4-5

2017

Link zum Volltext

Verfügbarkeit prüfen

Stage IB2 cervical cancer: Survival factors associated with treatment modality

Gynecologic oncology, 2017-06, Vol.145, p.146-146

2017

Link zum Volltext

Verfügbarkeit prüfen

Using value-based tools to determine the value of bevacizumab in cervical and ovarian cancer

Gynecologic oncology, 2017-06, Vol.145, p.62-63

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of adjuvant hysterectomy on prognosis in patients with locally advanced cervical cancer treated with definitive chemoradiation: A meta-analysis

Gynecologic oncology, 2017-06, Vol.145, p.183-183

2017

Link zum Volltext

Verfügbarkeit prüfen

Overcoming stress effects: A prospective feasibility trial of beta-blockers with upfront ovarian cancer therapy

Gynecologic oncology, 2017-06, Vol.145, p.18-18

2017

Link zum Volltext

Verfügbarkeit prüfen

Reasons for persistent suboptimal rates of HPV vaccination in the US: Shifting the focus from sexuality to education and awareness

Gynecologic oncology, 2017-06, Vol.145, p.4-4

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 4.433

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

ThemaScience & Technology

Zeitschrift / SerieGynecologic Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.433)
Mit Volltextzugriff
(4.433)

Publikationsform

Artikel
(4.427)
Reviews
(6)

Sprache

Englisch
(4.433)
Japanisch
(91)

Erscheinungsjahr

n.n

Thema

Obstetrics And Gynecology
(4.428)
Hematology, Oncology And Palliative Medicine
(4.363)
Humans
(139)
Female
(133)
Oncology
(91)
Adult
(49)
Middle Aged
(48)
Aged
(45)
Ovarian Cancer
(30)
Neoplasm Staging
(26)
Ovarian Neoplasms - Pathology
(23)
Ovarian Neoplasms - Drug Therapy
(21)
Aged, 80 And Over
(19)
Cervical Cancer
(18)
Cell Line, Tumor
(17)
Endometrial Neoplasms - Pathology
(16)
Immunohistochemistry
(16)
Uterine Cervical Neoplasms - Pathology
(16)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(15)
Disease-Free Survival
(15)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(4.433)
IngentaConnect
(4.433)
Elsevier ScienceDirect Journals Complete
(4.433)
IngentaConnect Journals
(4.365)
MEDLINE
(141)

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy of niraparib by timing of surgery and residual disease: a post-hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study

Worry and regret in the prospective multicentre TUBA study in mutation carriers

Randomized trial of adjuvant chemotherapy versus concurrent chemoradiotherapy in early-stage cervical cancer after radical surgery: A Chinese Gynecologic Oncology Group study (CSEM-002)

Identification of ovarian cancer patients for immunotherapy by concurrent assessment of tumor mutation burden (TMB), microsatellite instability (MSI) status, and targetable genomic alterations (GA)

Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance

Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer

Highlights from the Society of Gynecologic Oncology 2017 Annual Meeting on Women's Cancer

Corrigendum to “comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix” [Gynecol. Oncol. 145 (2017) 284–290]

Corrigendum to ‘Tumor diameter as a predictor of lymphatic dissemination in endometrioid endometrial cancer’ [Gynecol. Oncol. 141 (2016) 199–205]

Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A Trans PORTEC initiative

A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer

A comparison of tumor size at diagnosis and disease recurrence in type I and type II endometrial carcinoma

Role of lymphadenectomy and adjuvant treatment in high-risk endometrial cancer with positive lymph nodes: Comparison of a historical series with comprehensive surgical staging and a contemporary series with sentinel lymph nodes

Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy

Mortality reduction and cost-effectiveness of performing hysterectomy at the time of RRSO for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers

Sentinel lymph node biopsy for early cervical cancer: Five years follow-up of a diagnostic, prospective, multicenter study (Senticol 1)

No need to stress: Prospective clinical trial of adrenergic blockade during primary treatment in women with epithelial ovarian cancer

Sentinel lymph node biopsy for early cervical cancer: Results of a randomized prospective, multicenter study (Senticol 2) comparing adding pelvic lymph node dissection vs sentinel node biopsy only

Recurrence patterns after minimally invasive surgery for cervical cancer: Outcomes compared to traditional surgery

Hospital readmission as a quality measure in ovarian cancer surgery

Stage IB2 cervical cancer: Survival factors associated with treatment modality

Using value-based tools to determine the value of bevacizumab in cervical and ovarian cancer

Impact of adjuvant hysterectomy on prognosis in patients with locally advanced cervical cancer treated with definitive chemoradiation: A meta-analysis

Overcoming stress effects: A prospective feasibility trial of beta-blockers with upfront ovarian cancer therapy

Reasons for persistent suboptimal rates of HPV vaccination in the US: Shifting the focus from sexuality to education and awareness

Aktive Filter

Suchergebnisse filtern